Testing effectiveness (Phase 2)Study completedNCT05205746
What this trial is testing
Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence
Who this might be right for
SARS CoV 2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 158